Elastosis Perforans Serpignosa: Treatment with Liquid Nitrogen Cryotherapy and Review of the Literature

Abstract

French

Background:

Elastosis perforans serpiginosa (EPS) is a rare skin disease in which abnormal elastic tissue fibers, other connective tissue elements, and cellular debris are expelled from the papillary dermis via transepithelial elimination. It is characterized by an eruption of small grouped hyperkeratotic papules in a serpiginous arrangement. This condition presents a therapeutic challenge as many treatments have been reported with inconsistent efficacy.

Methods:

This article reports a case of a 13-year-old male who presented to our outpatient clinic with a 1-year history of facial lesions showing multiple annular keratotic plaques with slight central atrophy.

Conclusion:

We report a case of EPS treated successfully with liquid nitrogen cryotherapy. Liquid nitrogen cryotherapy is well tolerated, with few side effects, and can be considered in the management of EPS.

Get full access to this article

View all access options for this article.

References

Lewis

Bercovitch

Dill

. Acquired disorders of elastic tissue: Part I. Increased elastic tissue and solar elastotic syndromes. J Am Acad Dermatol 2004;51:1–21.

eMedicine World Medical Library. Elastosis perforans serpiginosum. Available at: http://www.emedicine.com/derm/topic116.htm (accessed June 2, 2008).

Rosenblum

. Liquid nitrogen cryotherapy in a case of elastosis perforans serpiginosa. J Am Acad Dermatol 1983;8:718–21.

Vearrier

Buka

Roberts

. What is standard of care in the evaluation of elastosis perforans serpiginosa? A survey of pediatric dermatologists. Pediatr Dermatol 2006;23:219–24.

Saxena

Tope

. Response of elastosis perforans serpiginosa to pulsed CO₂, Er: YAG, and dye lasers Dermatol Surg 2003;29: 677–8.

Rath

Bhardwaj

Kar

. Penicillamine induced pseudoxanthoma elasticum with elastosis perforans serpiginosa. Indian J Dermatol Venereol Leprol 2005;71:182–5.

Kelly

Purcell

. Imiquimod therapy for elastosis perforans serpiginosa. Arch Dermatol 2006;142:829–30.

Tuyp

McLeod

. Elastosis perforans serpiginosa: Treatment with liquid nitrogen. Int J Dermatol 1990;29:655–6.

Mehregan

. Elastosis perforans serpiginosa: A review of the literature and report of 11 cases. Arch Dermatol 1968;97:381–93.

10.

Abdullah

Colloby

Foulds

. Localized idiopathic elastosis perforans serpiginosa effectively treated by the Coherent Ultrapulse 5000C aesthetic laser. Int J Dermatol 2000;39:719–20.

11.

Mehta

Burrows

Payne

. Elastosis perforans serpiginosa and associated disorders. Clin Exp Dermatol 2001;26:521–4.

12.

Outland

Brown

Callen

. Tazarotene is an effective therapy for elastosis perforans serpiginosa. Arch Dermatol 2002;138:169–71.

13.

Ratnavel

Norris

. Penicillamine-induced elastosis perforans serpiginosa treated successfully with isotretinoin. Dermatology 1994;189:81–3.

14.

Kaufman

. Treatment of elastosis perforans serpiginosa with the flashlamp pulsed dye laser. Dermatol Surg 2000;26:1060–2.